In Situ Hybridization Market Trends

Statistics for the 2023 & 2024 In Situ Hybridization market trends, created by Mordor Intelligence™ Industry Reports. In Situ Hybridization trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of In Situ Hybridization Industry

This section covers the major market trends shaping the In Situ Hybridization Market according to our research experts:

The Fluorescence In Situ Hybridization (FISH) is Expected to Witness a Healthy Growth in the Market Over the Forecast Period

Fluorescence In Situ Hybridization (FISH ) is a laboratory technique used to detect and locate a specific DNA sequence on a chromosome from an individual that is affixed to a glass slide and then exposed to a probe, a mall piece of purified DNA tagged with a fluorescent dye. It is utilized to diagnose genetic diseases, cancer, gene mapping, and identification of chromosomal abnormalities. Factors for the growth of the FISH segment are growing genetic disorders, chronic diseases, and increasing demand for efficient diagnostic procedures.

For instance, the UN data published in March 2022 stated that the estimated incidence of Down syndrome is between 1 in 1,000 and 1 in 1,100 live births annually. The report also mentioned each year, approximately 3,000 to 5,000 children are born with this chromosome disorder. Also, as per the National Breast Cancer Foundation Inc., data published in June 2022 mentioned that in 2022, an estimated 287,500 new cases of invasive breast cancer is diagnosed in women in the United States and as well as 51,400 new cases of non-invasive breast cancer. The report also mentioned that an estimated 2,170 men are diagnosed with breast cancer in 2022 in the United States. Such rising prevalence of chromosomal disorders and chronic diseases is expected to drive the demand for early and effective diagnosis, thereby contributing to the growth of the studied segment.

Also, the rising product launches by various market players meet the growing demand for FISH techniques, thereby contributing to the market's growth. For instance, in May 2021, Vizgen launched its freely available data set as a part of its newly-launched Vizgen release program. The Vizgen multiplexed error robust fluorescence in situ hybridization mouse brain receptor map is an open-source spatial genomics dataset containing the exact position of transcripts from 483 genes.

Thus, the above-mentioned factors, such as the growing prevalence of various chronic disorders, rising demand for advanced techniques such as FISH, and increasing product launches, are expected to contribute to the growth of the studied segment.

In Situ Hybridization Market - Number of New Cases of Breast Cancer, By Type, United States, 2022

North America is Expected to Hold Significant Share in Situ Hybridization Market Over the Forecast Period

North America is expected to account for the major share in the in situ hybridization market, owing to the higher incidence of cancer in the region and the prevalence of infectious diseases and genetic disorders in the region. Additionally, the rising research and developmental activities, presence of key market players, and frequent product launches are expected to contribute to the market's growth.

For instance, according to the American Cancer Society Inc., data published in 2022, in 2021, there were an estimated 1.9 million new cancer cases diagnosed in the United States. In addition, according to the Public Health Agency of Canada data published in October 2021, approximately 2 in 5 Canadians were diagnosed with Cancer in their lifetime. In 2021, an estimated 229,000 Canadians were diagnosed with Cancer. The report also mentioned that lung, breast, colorectal, and prostate cancers were expected to remain the most commonly diagnosed cancers, accounting for nearly 46% of all cancer diagnoses in 2021. Such a high prevalence of cancers in North American countries is expected to contribute to the market's growth. High cancer incidence rates are expected to positively affect market demand for in situ hybridization products during the forecast period.

Additionally, the rising product launches by various key market players in this region are expected to contribute to the market's growth. For instance, in December 2022, OmicsVeu launched an extensive line of spatial biology products along with mRNA and DNA FISH probes and kits. A wide range of over 220 plus fluorophore-tagged miRNA probes enables the generation of multiplex miRNA profiling. Thus, given the above factors, North America is expected to dominate the in situ hybridization market over the forecast period owing to the rising chronic disorders and rising product launches by various key market players.

In Situ Hybridization Market - Growth Rate by Region

In Situ Hybridization Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)